2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$118.81+$3.78 (+3.29%)
Price as of Jun 23, 2026 5:08 PM EDT- $7.4BMarket Cap
- 115.57%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$118.81+$3.78 (+3.29%)
PTGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $115.03 | ||
Change | +$2.17 (+1.92%) | ||
Open | $113.24 | ||
High | $116.57 | ||
Low | $113.24 | ||
Previous Close | $112.86 | ||
Volume | 1,193,688 | ||
30-Day Average Volume | 700,987 | ||
1-Week Change | 2.29% | ||
1-Month Change | 15.97% | ||
1-Year Change | 115.57% | ||
3-Year Change | 317.68% | ||
5-Year Change | 165.05% | ||
Fundamentals | |||
Shares Outstanding | 64.3M | ||
Total Assets | $697.5M | ||
Market Cap | $7.4B | ||
Enterprise Value | $7.2B | ||
Period: QTR TTM FY | |||
Revenue | $56.4M | ||
Net Income | $3.8M | ||
Free Cash Flow | -$49.2M | ||
EBIT | $2.3M | ||
EBITDA | $2.7M | ||
Net Working Capital | $578.9M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 2,680 | ||
Enterprise Value/Revenue | 128 | ||
P/B | 11 | ||
P/E | 2,301 | ||
PEG | 21 | ||
Price/Free Cash Flow | -150 | ||
Price/Operating Cash Flow | -151 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue